Cargando…
Molecular mechanism of c‐Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma
Patients with relapsed/refractory Burkitt's lymphoma (BL) have a dismal prognosis. Current research efforts aim to increase cure rates by identifying high‐risk patients in need of more intensive or novel therapy. The 8q24 chromosomal translocation of the c‐Myc gene, a main molecular marker of B...
Autores principales: | Li, Ting, Song, Lili, Zhang, Yingwen, Han, Yali, Zhan, Zhiyan, Xv, Zhou, Li, Yang, Tang, Yuejia, Yang, Yi, Wang, Siqi, Li, Shanshan, Zheng, Liang, Li, Yanxin, Gao, Yijin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299692/ https://www.ncbi.nlm.nih.gov/pubmed/32391636 http://dx.doi.org/10.1111/jcmm.15322 |
Ejemplares similares
-
PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness
por: Yang, Yi, et al.
Publicado: (2021) -
PRPS2 mutations drive acute lymphoblastic leukemia relapse through influencing PRPS1/2 hexamer stability
por: Song, Lili, et al.
Publicado: (2022) -
The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient
por: Li, Yang, et al.
Publicado: (2020) -
NUDT15 polymorphism and NT5C2 and PRPS1 mutations influence thiopurine sensitivity in acute lymphoblastic leukaemia cells
por: Somazu, Shinpei, et al.
Publicado: (2021) -
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
por: De Falco, Giulia, et al.
Publicado: (2015)